The University of Chicago Header Logo

Connection

Jessica Donington to Humans

Back to Details
This is a "connection" page, showing publications Jessica Donington has written about Humans.
Jessica Donington
Connection Strength
1.498
Humans
  1. Current Management of Stage IIIA (N2) Non-Small-Cell Lung Cancer: Role of Perioperative Immunotherapy, and Tyrosine Kinase Inhibitors. Thorac Surg Clin. 2023 May; 33(2):189-196.
    View in: PubMed
    Score: 0.030
  2. Oncologic end points and implication of trial design in the era of immunotherapy for resectable non-small cell lung cancer. J Thorac Cardiovasc Surg. 2023 06; 165(6):1949-1953.
    View in: PubMed
    Score: 0.029
  3. Lung resection surgery in Jehovah's Witness patients: a 20-year single-center experience. J Cardiothorac Surg. 2022 Oct 20; 17(1):272.
    View in: PubMed
    Score: 0.029
  4. Integration of New Systemic Adjuvant Therapies for Non-small Cell Lung Cancer: Role of the Surgeon. Ann Thorac Surg. 2023 06; 115(6):1544-1555.
    View in: PubMed
    Score: 0.029
  5. Postoperative Complications of Thymectomy in Myasthenia Gravis: Does Steroid Use Play a Role? Ann Thorac Surg. 2023 06; 115(6):1558.
    View in: PubMed
    Score: 0.029
  6. Neoadjuvant Immunotherapy for Resectable Non-small Cell Lung Cancer: Exciting New Horizon in Early-Stage Lung Cancer Care. Ann Surg Oncol. 2022 09; 29(9):5344-5346.
    View in: PubMed
    Score: 0.028
  7. The Increasing Role of Surgery in Comprehensive Treatment of Advanced Non-small Cell Lung Cancer with Targetable Mutations. Ann Surg Oncol. 2022 08; 29(8):4679-4680.
    View in: PubMed
    Score: 0.028
  8. Surgical Issues for Operable Early-Stage Non-Small-Cell Lung Cancer. J Clin Oncol. 2022 02 20; 40(6):530-538.
    View in: PubMed
    Score: 0.028
  9. Commentary: Why do we operate in metastatic lung cancer? J Thorac Cardiovasc Surg. 2022 03; 163(3):826-827.
    View in: PubMed
    Score: 0.026
  10. 2020 Women in Thoracic Surgery Update on the Status of Women in Cardiothoracic Surgery. Ann Thorac Surg. 2022 03; 113(3):918-925.
    View in: PubMed
    Score: 0.026
  11. Clinical predictors of donor antibody titre and correlation with recipient antibody response in a COVID-19 convalescent plasma clinical trial. J Intern Med. 2021 04; 289(4):559-573.
    View in: PubMed
    Score: 0.026
  12. STS 2019 Workforce Report: Ad Hoc Analysis of Women in Cardiothoracic Surgery. Ann Thorac Surg. 2021 02; 111(2):383-385.
    View in: PubMed
    Score: 0.025
  13. Resection following concurrent chemotherapy and high-dose radiation for stage IIIA non-small cell lung cancer. J Thorac Cardiovasc Surg. 2020 11; 160(5):1331-1345.e1.
    View in: PubMed
    Score: 0.025
  14. Lung Cancer: Advances in Diagnosis and Management. Semin Respir Crit Care Med. 2020 Jun; 41(3):333-334.
    View in: PubMed
    Score: 0.025
  15. Update on Lung Cancer Screening. Semin Respir Crit Care Med. 2020 Jun; 41(3):447-452.
    View in: PubMed
    Score: 0.025
  16. Commentary: Why does neoadjuvant therapy suddenly make sense for early stage non-small cell lung cancer? J Thorac Cardiovasc Surg. 2020 11; 160(5):1383-1384.
    View in: PubMed
    Score: 0.025
  17. Commentary: The need to RIOT (return to intended oncologic treatment) after lung cancer surgery. J Thorac Cardiovasc Surg. 2019 07; 158(1):287-288.
    View in: PubMed
    Score: 0.023
  18. The Role of Surgery in Management of Locally Advanced Non-Small Cell Lung Cancer. Curr Treat Options Oncol. 2019 03 14; 20(4):27.
    View in: PubMed
    Score: 0.023
  19. Early-Stage NSCLC: Advances in Thoracic Oncology 2018. J Thorac Oncol. 2019 06; 14(6):968-978.
    View in: PubMed
    Score: 0.023
  20. Commentary: Keeping surgery relevant in oligometastatic non-small cell lung cancer. J Thorac Cardiovasc Surg. 2019 04; 157(4):1629-1630.
    View in: PubMed
    Score: 0.022
  21. Thoracotomy for Stage I Lung Cancer Resections: A Procedure Past Its Time. J Clin Oncol. 2018 08 10; 36(23):2361-2362.
    View in: PubMed
    Score: 0.022
  22. Progress in the Management of Early-Stage Non-Small Cell Lung Cancer in 2017. J Thorac Oncol. 2018 06; 13(6):767-778.
    View in: PubMed
    Score: 0.021
  23. Making computed tomographic screening accessible for all. J Thorac Cardiovasc Surg. 2018 06; 155(6):2682.
    View in: PubMed
    Score: 0.021
  24. Give Resection a Chance. Int J Radiat Oncol Biol Phys. 2017 11 15; 99(4):767-768.
    View in: PubMed
    Score: 0.021
  25. Salvage Resections for Stage III Non-small Cell Lung Cancer: A Curious Area of Investigation. Semin Thorac Cardiovasc Surg. 2017; 29(2):242-243.
    View in: PubMed
    Score: 0.020
  26. Marjolin's Ulcer of the Pleural Surface Within a Long-Standing Eloesser Flap. Ann Thorac Surg. 2016 Nov; 102(5):e383-e385.
    View in: PubMed
    Score: 0.019
  27. Surgical Treatment of Early l Stage Lung Cancer: What has Changed and What will Change in the Future. Semin Respir Crit Care Med. 2016 10; 37(5):708-715.
    View in: PubMed
    Score: 0.019
  28. Sublobar Resection: Ongoing Controversy for Treatment for Stage I Non-Small Cell Lung Cancer. Thorac Surg Clin. 2016 Aug; 26(3):251-9.
    View in: PubMed
    Score: 0.019
  29. An Additional Step Toward Personalization of Surgical Care for Early-Stage Non-Small-Cell Lung Cancer. J Clin Oncol. 2016 Feb 01; 34(4):295-6.
    View in: PubMed
    Score: 0.018
  30. Survival After Sublobar Resection Versus Lobectomy for Clinical Stage IA Lung Cancer: Analysis From the National Cancer Database. J Thorac Oncol. 2015 Nov; 10(11):1513-4.
    View in: PubMed
    Score: 0.018
  31. Radiofrequency ablation in high-risk stage I non-small cell lung cancer. Cancer. 2015 Oct 01; 121(19):3393-4.
    View in: PubMed
    Score: 0.018
  32. Surgical resection of non-small cell lung cancer with N2 disease. Thorac Surg Clin. 2014 Nov; 24(4):449-56.
    View in: PubMed
    Score: 0.017
  33. Managing lung cancer in high-risk patients: what to consider. Expert Rev Respir Med. 2014 Aug; 8(4):443-52.
    View in: PubMed
    Score: 0.016
  34. Invited commentary. Ann Thorac Surg. 2013 Dec; 96(6):1951.
    View in: PubMed
    Score: 0.016
  35. Management of the Apical Tumor: May 4, 2013, Minneapolis, MN. Semin Thorac Cardiovasc Surg. 2013; 25(3):256-71.
    View in: PubMed
    Score: 0.016
  36. Response. Chest. 2013 May; 143(5):1518-1519.
    View in: PubMed
    Score: 0.015
  37. Surgical approach to locally advanced non-small cell lung cancer. Cancer J. 2013 May-Jun; 19(3):217-21.
    View in: PubMed
    Score: 0.015
  38. Invited commentary. Ann Thorac Surg. 2013 Apr; 95(4):1188.
    View in: PubMed
    Score: 0.015
  39. Invited commentary. Ann Thorac Surg. 2013 Feb; 95(2):418-9.
    View in: PubMed
    Score: 0.015
  40. Current readings: sublobar resection for non-small-cell lung cancer. Semin Thorac Cardiovasc Surg. 2013; 25(1):22-9.
    View in: PubMed
    Score: 0.015
  41. American College of Chest Physicians and Society of Thoracic Surgeons consensus statement for evaluation and management for high-risk patients with stage I non-small cell lung cancer. Chest. 2012 Dec; 142(6):1620-1635.
    View in: PubMed
    Score: 0.015
  42. The WTS report on the current status of women in cardiothoracic surgery. Ann Thorac Surg. 2012 Aug; 94(2):452-8; discussion 458-9.
    View in: PubMed
    Score: 0.014
  43. Point: are limited resections appropriate in non-small cell lung cancer? Yes. Chest. 2012 Mar; 141(3):588-590.
    View in: PubMed
    Score: 0.014
  44. Invited commentary. Ann Thorac Surg. 2012 Feb; 93(2):403-4.
    View in: PubMed
    Score: 0.014
  45. Plasma osteopontin velocity differentiates lung cancers from controls in a CT screening population. Cancer Biomark. 2012; 12(4):177-84.
    View in: PubMed
    Score: 0.014
  46. Management of early stage non-small cell lung cancer in high-risk patients. Thorac Surg Clin. 2012 Feb; 22(1):55-65, vi.
    View in: PubMed
    Score: 0.014
  47. Invited commentary. Ann Thorac Surg. 2011 Jul; 92(1):250.
    View in: PubMed
    Score: 0.013
  48. Novel therapies for non-small cell lung cancer. J Thorac Imaging. 2011 May; 26(2):175-85.
    View in: PubMed
    Score: 0.013
  49. Sex and gender differences in non-small cell lung cancer. Semin Thorac Cardiovasc Surg. 2011; 23(2):137-45.
    View in: PubMed
    Score: 0.013
  50. Infections and radiation injuries involving the chest wall. Thorac Surg Clin. 2010 Nov; 20(4):487-94.
    View in: PubMed
    Score: 0.013
  51. Massive bronchogenic cyst. J Thorac Oncol. 2010 Nov; 5(11):1862-3.
    View in: PubMed
    Score: 0.013
  52. Functional heterogeneity of osteopontin isoforms in non-small cell lung cancer. J Thorac Oncol. 2010 Oct; 5(10):1516-23.
    View in: PubMed
    Score: 0.013
  53. Sublobar resection: a movement from the Lung Cancer Study Group. J Thorac Oncol. 2010 Oct; 5(10):1583-93.
    View in: PubMed
    Score: 0.013
  54. Reduction of elevated plasma osteopontin levels with resection of non-small-cell lung cancer. J Clin Oncol. 2010 Feb 20; 28(6):936-41.
    View in: PubMed
    Score: 0.012
  55. Lung cancer osteopontin isoforms exhibit angiogenic functional heterogeneity. J Thorac Cardiovasc Surg. 2010 Jun; 139(6):1587-93.
    View in: PubMed
    Score: 0.012
  56. Invited commentary. Ann Thorac Surg. 2009 Jun; 87(6):1702.
    View in: PubMed
    Score: 0.012
  57. The role of surgery in the treatment of stage III non-small-cell lung cancer. Curr Oncol Rep. 2007 Jul; 9(4):247-54.
    View in: PubMed
    Score: 0.010
  58. Management of locally advanced non small cell lung cancer from a surgical perspective. Curr Treat Options Oncol. 2007 Feb; 8(1):1-14.
    View in: PubMed
    Score: 0.010
  59. Results of a phase I dose-escalation study using single-fraction stereotactic radiotherapy for lung tumors. J Thorac Oncol. 2006 Oct; 1(8):802-9.
    View in: PubMed
    Score: 0.010
  60. Lung cancer in women: exploring sex differences in susceptibility, biology, and therapeutic response. Clin Lung Cancer. 2006 Jul; 8(1):22-9.
    View in: PubMed
    Score: 0.009
  61. Functional conduit disorders after esophagectomy. Thorac Surg Clin. 2006 Feb; 16(1):53-62.
    View in: PubMed
    Score: 0.009
  62. Unusual placement of an endotracheal tube in a patient with blunt traumatic airway injuries. Air Med J. 2006 Jan-Feb; 25(1):40-2.
    View in: PubMed
    Score: 0.009
  63. Preoperative preparation for esophageal surgery. Thorac Surg Clin. 2005 May; 15(2):277-85.
    View in: PubMed
    Score: 0.009
  64. Preoperative chemoradiation therapy does not improve early survival after esophagectomy for patients with clinical stage III adenocarcinoma of the esophagus. Ann Thorac Surg. 2004 Apr; 77(4):1193-8; discussion 1198-9.
    View in: PubMed
    Score: 0.008
  65. Tumor response to induction chemoradiation: influence on survival after esophagectomy. Eur J Cardiothorac Surg. 2003 Oct; 24(4):631-6; discussion 636-7.
    View in: PubMed
    Score: 0.008
  66. Germline Variants Incidentally Detected via Tumor-Only Genomic Profiling of Patients With Mesothelioma. JAMA Netw Open. 2023 08 01; 6(8):e2327351.
    View in: PubMed
    Score: 0.008
  67. Hamartomas of the lung. Semin Thorac Cardiovasc Surg. 2003 Jul; 15(3):301-4.
    View in: PubMed
    Score: 0.008
  68. American Radium Society Appropriate Use Criteria for Radiation Therapy in the Multidisciplinary Management of Thymic Carcinoma. JAMA Oncol. 2023 07 01; 9(7):971-980.
    View in: PubMed
    Score: 0.008
  69. Treatment Decisions for Resectable Non-Small-Cell Lung Cancer: Balancing Less With More? Am Soc Clin Oncol Educ Book. 2023 May; 43:e389950.
    View in: PubMed
    Score: 0.008
  70. STK11 Inactivation Predicts Rapid Recurrence in Inoperable Early-Stage Non-Small-Cell Lung Cancer. JCO Precis Oncol. 2023 01; 7:e2200273.
    View in: PubMed
    Score: 0.007
  71. Impact of Federal Lung Cancer Screening Policy on the Incidence of Early-stage Lung Cancer. Ann Thorac Surg. 2023 04; 115(4):827-833.
    View in: PubMed
    Score: 0.007
  72. Brief Report: Chylothorax and Chylous Ascites During RET Tyrosine Kinase Inhibitor Therapy. J Thorac Oncol. 2022 09; 17(9):1130-1136.
    View in: PubMed
    Score: 0.007
  73. Subsequent pulmonary resection for bronchogenic carcinoma after pneumonectomy. Ann Thorac Surg. 2002 Jul; 74(1):154-8; discussion 158-9.
    View in: PubMed
    Score: 0.007
  74. The Effect of Normothermic Machine Perfusion on the Immune Profile of Donor Liver. Front Immunol. 2022; 13:788935.
    View in: PubMed
    Score: 0.007
  75. Donor leukocyte trafficking during human ex vivo lung perfusion. Clin Transplant. 2022 07; 36(7):e14670.
    View in: PubMed
    Score: 0.007
  76. Women in Thoracic Surgery 2020 Update-Subspecialty and Work-Life Balance Analysis. Ann Thorac Surg. 2022 11; 114(5):1933-1942.
    View in: PubMed
    Score: 0.007
  77. Consensus for Thoracoscopic Lower Lobectomy: Essential Components and Targets for Simulation. Ann Thorac Surg. 2022 11; 114(5):1895-1901.
    View in: PubMed
    Score: 0.007
  78. CDKN2A loss-of-function predicts immunotherapy resistance in non-small cell lung cancer. Sci Rep. 2021 10 08; 11(1):20059.
    View in: PubMed
    Score: 0.007
  79. American Radium Society Appropriate Use Criteria for Radiation Therapy in Oligometastatic or Oligoprogressive Non-Small Cell Lung Cancer. Int J Radiat Oncol Biol Phys. 2022 02 01; 112(2):361-375.
    View in: PubMed
    Score: 0.007
  80. Pulmonary Parenchymal Changes in COVID-19 Survivors. Ann Thorac Surg. 2022 07; 114(1):301-310.
    View in: PubMed
    Score: 0.007
  81. Determinants of electrocardiographic abnormalities in patients with pectus excavatum. J Electrocardiol. 2021 Mar-Apr; 65:91-95.
    View in: PubMed
    Score: 0.007
  82. SARS-CoV-2 Infection Severity Is Linked to Superior Humoral Immunity against the Spike. mBio. 2021 01 19; 12(1).
    View in: PubMed
    Score: 0.006
  83. American Radium Society Appropriate Use Criteria: Radiation Therapy for Limited-Stage SCLC 2020. J Thorac Oncol. 2021 01; 16(1):66-75.
    View in: PubMed
    Score: 0.006
  84. Consensus for Thoracoscopic Left Upper Lobectomy-Essential Components and Targets for Simulation. Ann Thorac Surg. 2021 08; 112(2):436-442.
    View in: PubMed
    Score: 0.006
  85. Fair and equitable subject selection in concurrent COVID-19 clinical trials. J Med Ethics. 2021 01; 47(1):7-11.
    View in: PubMed
    Score: 0.006
  86. American Radium Society Appropriate Use Criteria on Radiation Therapy for Extensive-Stage SCLC. J Thorac Oncol. 2021 01; 16(1):54-65.
    View in: PubMed
    Score: 0.006
  87. Alternative Multidisciplinary Management Options for Locally Advanced NSCLC During the Coronavirus Disease 2019 Global Pandemic. J Thorac Oncol. 2020 07; 15(7):1137-1146.
    View in: PubMed
    Score: 0.006
  88. Is it ethically appropriate to continue surgical clinical trials during the COVID-19 pandemic? Surgery. 2020 07; 168(1):1-3.
    View in: PubMed
    Score: 0.006
  89. A Systematic Review of Digital vs Analog Drainage for Air Leak After Surgical Resection or Spontaneous Pneumothorax. Chest. 2020 05; 157(5):1346-1353.
    View in: PubMed
    Score: 0.006
  90. The IASLC Lung Cancer Staging Project: Analysis of Resection Margin Status and Proposals for Residual Tumor Descriptors for Non-Small Cell Lung Cancer. J Thorac Oncol. 2020 03; 15(3):344-359.
    View in: PubMed
    Score: 0.006
  91. Sexual Harassment and Cardiothoracic Surgery: #UsToo? Ann Thorac Surg. 2020 04; 109(4):1283-1288.
    View in: PubMed
    Score: 0.006
  92. Gender Bias and Its Negative Impact on Cardiothoracic Surgery. Ann Thorac Surg. 2020 01; 109(1):14-17.
    View in: PubMed
    Score: 0.006
  93. Evaluation of the airway microbiome in nontuberculous mycobacteria disease. Eur Respir J. 2018 10; 52(4).
    View in: PubMed
    Score: 0.006
  94. Molecular Testing Guideline for the Selection of Patients With Lung Cancer for Treatment With Targeted Tyrosine Kinase Inhibitors: American Society of Clinical Oncology Endorsement of the College of American Pathologists/International Association for the Study of Lung Cancer/Association for Molecular Pathology Clinical Practice Guideline Update. J Clin Oncol. 2018 03 20; 36(9):911-919.
    View in: PubMed
    Score: 0.005
  95. The value of collaboration between thoracic surgeons and radiation oncologists while awaiting evidence in operable stage i non-small cell lung cancer. J Thorac Cardiovasc Surg. 2018 Jan; 155(1):429-431.
    View in: PubMed
    Score: 0.005
  96. Randomized Phase II Study of Preoperative Chemoradiotherapy ± Panitumumab Followed by Consolidation Chemotherapy in Potentially Operable Locally Advanced (Stage IIIa, N2+) Non-Small Cell Lung Cancer: NRG Oncology RTOG 0839. J Thorac Oncol. 2017 09; 12(9):1413-1420.
    View in: PubMed
    Score: 0.005
  97. Stereotactic body radiation therapy for early-stage non-small cell lung cancer: Executive Summary of an ASTRO Evidence-Based Guideline. Pract Radiat Oncol. 2017 Sep - Oct; 7(5):295-301.
    View in: PubMed
    Score: 0.005
  98. An Old Solution for a New Problem: Eloesser Flap Management of Infected Defibrillator Patches. Ann Thorac Surg. 2017 Jun; 103(6):e497-e498.
    View in: PubMed
    Score: 0.005
  99. Scientific Advances in Thoracic Oncology 2016. J Thorac Oncol. 2017 08; 12(8):1183-1209.
    View in: PubMed
    Score: 0.005
  100. The IASLC Lung Cancer Staging Project: Background Data and Proposals for the Application of TNM Staging Rules to Lung Cancer Presenting as Multiple Nodules with Ground Glass or Lepidic Features or a Pneumonic Type of Involvement in the Forthcoming Eighth Edition of the TNM Classification. J Thorac Oncol. 2016 05; 11(5):666-680.
    View in: PubMed
    Score: 0.005
  101. The IASLC Lung Cancer Staging Project: Summary of Proposals for Revisions of the Classification of Lung Cancers with Multiple Pulmonary Sites of Involvement in the Forthcoming Eighth Edition of the TNM Classification. J Thorac Oncol. 2016 05; 11(5):639-650.
    View in: PubMed
    Score: 0.005
  102. The IASLC Lung Cancer Staging Project: Background Data and Proposals for the Classification of Lung Cancer with Separate Tumor Nodules in the Forthcoming Eighth Edition of the TNM Classification for Lung Cancer. J Thorac Oncol. 2016 05; 11(5):681-692.
    View in: PubMed
    Score: 0.005
  103. The IASLC Lung Cancer Staging Project: Background Data and Proposed Criteria to Distinguish Separate Primary Lung Cancers from Metastatic Foci in Patients with Two Lung Tumors in the Forthcoming Eighth Edition of the TNM Classification for Lung Cancer. J Thorac Oncol. 2016 05; 11(5):651-665.
    View in: PubMed
    Score: 0.005
  104. Plasma Biomarker Enrichment of Clinical Prognostic Indices in Malignant Pleural Mesothelioma. J Thorac Oncol. 2016 06; 11(6):900-9.
    View in: PubMed
    Score: 0.005
  105. Women in Thoracic Surgery: 30 Years of History. Ann Thorac Surg. 2016 Jan; 101(1):399-409.
    View in: PubMed
    Score: 0.005
  106. Local Therapy for Limited Metastatic Non-Small Cell Lung Cancer: What Are the Options and Is There a Benefit? Am Soc Clin Oncol Educ Book. 2016; 35:e460-7.
    View in: PubMed
    Score: 0.005
  107. Use of photodynamic therapy for the management of pleural malignancies. Semin Surg Oncol. 1995 Sep-Oct; 11(5):360-7.
    View in: PubMed
    Score: 0.004
  108. Malignant pleural mesothelioma: newer aspects of carcinogenesis, molecular genetics, and prospects for future therapies. Surg Oncol. 1995 Aug; 4(4):175-85.
    View in: PubMed
    Score: 0.004
  109. Treatment of recalcitrant subcutaneous emphysema using negative pressure wound therapy dressings. BMJ Case Rep. 2014 Nov 09; 2014.
    View in: PubMed
    Score: 0.004
  110. Overexpression of EPH receptor B2 in malignant mesothelioma correlates with oncogenic behavior. J Thorac Oncol. 2013 Sep; 8(9):1203-11.
    View in: PubMed
    Score: 0.004
  111. Evaluation of individuals with pulmonary nodules: when is it lung cancer? Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2013 May; 143(5 Suppl):e93S-e120S.
    View in: PubMed
    Score: 0.004
  112. Fibulin-3 as a blood and effusion biomarker for pleural mesothelioma. N Engl J Med. 2012 Oct 11; 367(15):1417-27.
    View in: PubMed
    Score: 0.004
  113. A pilot cohort study of the determinants of longitudinal opioid use after surgery. Anesth Analg. 2012 Sep; 115(3):694-702.
    View in: PubMed
    Score: 0.004
  114. Results from a single institution phase II trial of concurrent docetaxel/carboplatin/radiotherapy followed by surgical resection and consolidation docetaxel/carboplatin in stage III non-small-cell lung cancer. Clin Lung Cancer. 2011 Sep; 12(5):280-5.
    View in: PubMed
    Score: 0.003
  115. Tumor volume as a potential imaging-based risk-stratification factor in trimodality therapy for locally advanced non-small cell lung cancer. J Thorac Oncol. 2011 May; 6(5):920-6.
    View in: PubMed
    Score: 0.003
  116. Onconase mediated NFKß downregulation in malignant pleural mesothelioma. Oncogene. 2011 Jun 16; 30(24):2767-77.
    View in: PubMed
    Score: 0.003
  117. Simulating video-assisted thoracoscopic lobectomy: a virtual reality cognitive task simulation. J Thorac Cardiovasc Surg. 2011 Jan; 141(1):249-55.
    View in: PubMed
    Score: 0.003
  118. Frequency of use and predictors of cancer-directed surgery in the management of malignant pleural mesothelioma in a community-based (Surveillance, Epidemiology, and End Results [SEER]) population. J Thorac Oncol. 2010 Oct; 5(10):1649-54.
    View in: PubMed
    Score: 0.003
  119. hsa-miR-29c* is linked to the prognosis of malignant pleural mesothelioma. Cancer Res. 2010 Mar 01; 70(5):1916-24.
    View in: PubMed
    Score: 0.003
  120. Initial experience with endobronchial ultrasound in an academic thoracic surgery program. Clin Lung Cancer. 2010 Jan; 11(1):25-9.
    View in: PubMed
    Score: 0.003
  121. Tracheal glomangioma in a patient with asthma and chest pain. J Clin Oncol. 2010 Jan 10; 28(2):e9-e10.
    View in: PubMed
    Score: 0.003
  122. Complications of ablative therapies in lung cancer. Clin Lung Cancer. 2008 Mar; 9(2):122-6.
    View in: PubMed
    Score: 0.003
  123. Metabolic tumor burden predicts for disease progression and death in lung cancer. Int J Radiat Oncol Biol Phys. 2007 Oct 01; 69(2):328-33.
    View in: PubMed
    Score: 0.003
  124. A multidisciplinary approach to management in a patient with bilateral superior sulcus non-small-cell lung carcinoma. Clin Lung Cancer. 2006 Sep; 8(2):146-8.
    View in: PubMed
    Score: 0.002
  125. An evaluation of tumor oxygenation and gene expression in patients with early stage non-small cell lung cancers. Clin Cancer Res. 2006 Mar 01; 12(5):1507-14.
    View in: PubMed
    Score: 0.002
  126. Case 5--2005: anesthetic management of major hemorrhage during mediastinoscopy. [clin conf]. J Cardiothorac Vasc Anesth. 2005 Oct; 19(5):678-83.
    View in: PubMed
    Score: 0.002
  127. Recurrence of pulmonary intravascular bronchoalveolar tumor with mediastinal metastasis 20 years later. Respir Med. 2006 Feb; 100(2):367-70.
    View in: PubMed
    Score: 0.002
  128. Human mesotheliomas contain the simian virus-40 regulatory region and large tumor antigen DNA sequences. J Thorac Cardiovasc Surg. 1998 Nov; 116(5):854-9.
    View in: PubMed
    Score: 0.001
  129. Further validation of SV40-like DNA in human pleural mesotheliomas. Dev Biol Stand. 1998; 94:143-5.
    View in: PubMed
    Score: 0.001
  130. The effect of an antisense expression plasmid to the IGF-1 receptor on hamster mesothelioma proliferation. Dev Biol Stand. 1998; 94:321-8.
    View in: PubMed
    Score: 0.001
  131. Isolated lung perfusion with tumor necrosis factor for pulmonary metastases. Ann Thorac Surg. 1996 Jun; 61(6):1609-17.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.